SG Americas Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
SG Americas Securities's ELV Position: Q1 2026 in Review
SG Americas Securities increased its Elevance Health (ELV) stake by 239% in Q1 2026, buying an estimated $184M and bringing the position to 796,553 shares worth $233M. The position accounts for 0.25% of the portfolio, ranked #59.
SG Americas Securities first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- SG Americas Securities held 796,553 shares of Elevance Health worth $233M as of Q1 2026.
- SG Americas Securities bought 561,300 Elevance Health shares in Q1 2026, an estimated $184M.
- Elevance Health made up 0.25% of SG Americas Securities's portfolio in Q1 2026, its #59 holding.
- SG Americas Securities first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.